Cargando…
Efficacy and Safety of Avanafil in Chinese Subjects With Erectile Dysfunction: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial
INTRODUCTION: The incidence of erectile dysfunction (ED) increases with age in mainland China and phosphodiesterase 5 inhibitors (PDE5i) are the major drugs used for its treatment. AIM: To determine the efficacy and safety of Chinese developed avanafil as therapy for ED in China. METHODS: This phase...
Autores principales: | Jiang, Hui, Lin, Haocheng, Li, Fubiao, Dai, Yutian, Zhang, Xiangsheng, Jiang, Tao, Deng, Junhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240155/ https://www.ncbi.nlm.nih.gov/pubmed/33685839 http://dx.doi.org/10.1016/j.esxm.2021.100337 |
Ejemplares similares
-
Avanafil for erectile dysfunction
Publicado: (2019) -
Future prospects in the treatment of erectile dysfunction: focus on avanafil
por: Alwaal, Amjad, et al.
Publicado: (2011) -
Avanafil for treatment of erectile dysfunction: review of its potential
por: Burke, Ryan M, et al.
Publicado: (2012) -
A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction
por: Park, Hyun Jun, et al.
Publicado: (2017) -
Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial
por: Kumar, Manish, et al.
Publicado: (2022)